Ann: IMUGENE DOSES FIRST PATIENT IN VAXINIA PHASE 1 TRIAL, page-53

Thanks for the video, GMT2.

While the market reaction to this announcement is crap as expected the interview explains very well what is in store - a cancer killing technology for almost all / all types and varieties.

IMU's B-cell tech vaccines have already proven that anything that IMU has been trialed so far has outperformed all existing drugs in safety and efficacy. No accidents or coincidences - these are based strong pre-clinical results. And that's the PH recipe - licence only drugs / tech that have an above average chance of success based on the pre-clinical results, surround yourself with the best in their field and put ethics before money - that way success is hardly to be missed.

While some are selling it is an even stronger buy signal for me.

GLTA